Skip to main content
12/05/2014 - 11:39

Admedus raises $8m for CardioCel

12/05/2014 - 11:39

Bookmark

Save articles for future reference.

Biotech company Admedus has completed an oversubscribed $8 million share placement as it looks to push marketing for its CardioCel regenerative tissue product in Europe and the US.

X

To read our articles you will need to either login or subscribe.